Brush-based cytology screening in the tonsils and cervix: There is a difference!

Cancer Prevention Research

Volumn 4, Issue 9, 2011, Pages 1350-1352

  Lingen, Mark W ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CYTODIAGNOSIS; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY CANCER; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; OROPHARYNX CANCER; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PATIENT IDENTIFICATION; PRECANCER; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TECHNIQUE; TONSIL CANCER; UTERINE CERVIX CANCER; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CERVIX UTERI; CYTODIAGNOSIS; CYTOLOGICAL TECHNIQUES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MASS SCREENING; MODELS, BIOLOGICAL; PALATINE TONSIL; PAPILLOMAVIRIDAE; VAGINAL SMEARS;

EID: 80052592015     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0373     Document Type: Review

References (26)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Blot W.J., McLaughlin J.K., Winn D.M., Austin D.F., Greenberg RS, Preston- Martin S, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988;48:3282-3287
3. Chaturvedi A.K., Engels E.A., Anderson W.F., Gillison M.L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008;26:612-619 (Pubitemid 351264356)
4. Gillison M.L., D'Souza G., Westra W., Sugar E., Xiao W., Begum S., et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100:407-420 (Pubitemid 351480511)
5. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-720 (Pubitemid 30365531)
6. D'Souza G., Kreimer A.R., Viscidi R., Pawlita M., Fakhry C., Koch W.M., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-1956 (Pubitemid 46740304)
7. Fakhry C., Westra W.H., Li S., Cmelak A., Ridge J.A., Pinto H., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261-269 (Pubitemid 351480538)
8. Schlecht N.F. Prognostic value of human papillomavirus in the survival of head and neck cancer patients: An overview of the evidence. Oncol Rep 2005;14:1239-1247
9. Sausville E.A., Burke W., Colice G., Emerson S., Harris R., Klein J.S., et al. Statement concerning the National Lung Screening Trial. 2010 Oct 28 [cited 2011 Jul 10]. Available from:http://www.cancer.gov/images/ dsmb-nlst.pdf
10. Nelson H.D., Tyne K., Naik A., Bougatsos C., Chan B.K., Humphrey L., et al. Screening for breast cancer: An update for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151:727-737
11. Lingen M.W., Kalmar J.R., Karrison T., Speight P.M. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 2008; 44:10-22. (Pubitemid 350258631)
12. Patton L.L., Epstein J.B., Kerr A.R. Adjunctive techniques for oral cancer examination and lesion diagnosis: A systematic review of the literature. J Am Dent Assoc 2008;139:896-905.
13. Rethman M.P., Carpenter W., Cohen E.E., Epstein J., Evans C.A., Flaitz C.M., et al. Evidence-based clinical recommendations regardingscreening for oral squamous cell carcinomas. J Am Dent Assoc 2010;141:509-520
14. Lingen M.W. Screening for oral premalignancy and cancer: What platform and which biomarkers? Cancer Prev Res 2010;3:1056-1059
15. Fakhry C., Rosenthal B.T., Clark D.P., Gillison M.L. Associations between oral HPV16 infection and cytopathology: Evaluation of an oropharyngeal "Pap-test equivalent" in high-risk populations. Cancer Prev Res 2011;4:1378-1384
16. Saslow D., Runowicz C.D., Solomon D., Moscicki A.B., Smith R.A., Eyre H.J., et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-362 (Pubitemid 35446606)
17. Gustafsson L., Ponten J., Bergstrom R., Adami H.O. International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer 1997;71:159-165 (Pubitemid 27252984)
18. Gustafsson L., Ponten J., Zack M., Adami H.O. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 1997;8:755-763 (Pubitemid 27404646)
19. Westra W. The changing face of head and neck cancer in the 21st century: The impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol 2009;3:78-81.
20. Lingen M.W. Can saliva-based HPV tests establish cancer risk and guide patient management? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110:273-274
21. Genital HPV Infection-Fact Sheet [Cited 2011 Jul 10]. Available from: http://www.cdc.gov/std/HPV/STDFact-HPV.htm#common
22. Park I.S., Chang X., Loyo M., Wu G., Chuang A., Kim M.S., et al. Characterizationof the methylation patterns inhumanpapillomavirus type 16 viral DNA in head and neck cancers. Cancer Prev Res 2011;4:207-217
23. Blum G., Von Degenfeld F., Merchant M.J., Blau H.M., Bogyo M. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nat Chem Biol 2007;3: 668-687
24. Darragh M.R., Schneider E.L., Lou J., Phojanakong P.J., Farady C.J., Marks J.D., et al. Tumor dection by imaging proteolytic activity. Cancer Res 2010;70:1505-1512
25. Chen A.K., Rhee W.J., Bao G., Tsourkas A. Delivery of molecular beacons for live-cell imaging and anlysis of RNA. Methods Mol Biol 2011;714:159-174
26. Lu S., Wang Y. Fluorescence resonance energy transfer biosensors for cancer detection and evaluation of drug efficacy. Clin Cancer Res 2010;16:3822-3824